SPH PharmaceuticalTechnologyco.,Ltd

Biopharmaceutical innovation arm of Shanghai Pharmaceuticals, identifying and in-licensing Chinese rights to novel therapeutics, acting as the bridge between overseas partners and the group for clinical development and registration in China, and running its own research programmes in the United States and China across CNS, oncology and metabolic disease.